Sales grew 13 per cent at Rs 1,758 crore.
The expectations were high due to the month of monsoon which is considered good for the drug companies.
The revenue was expected to grow by 20 per cent.
Shares of the company were trading 5.10 per cent lower closed at Rs 320.00 after hitting a monthly low of Rs 323.20 in the early trade.
In a similar fashion, shares of the company at Rs 325.00, down 5.00 per cent on the National Stock Exchange.
Meanwhile, the broader benchmark Sensex was quoting closed at 17848.57 up by 75.73 points or 0.43%.